These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2856051)

  • 1. Effect of enalapril treatment on progression of the nephrotoxic serum nephritis model of renal failure in the rat.
    Jackson B; Debrevi L
    Clin Exp Pharmacol Physiol; 1988 Feb; 15(2):131-6. PubMed ID: 2856051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetic nephropathy in the rat: differing renal effects of an angiotensin converting enzyme inhibitor and a calcium inhibitor.
    Whitty MR; Jackson B
    Diabetes Res; 1988 Jun; 8(2):91-6. PubMed ID: 2852570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat.
    Remuzzi A; Puntorieri S; Battaglia C; Bertani T; Remuzzi G
    J Clin Invest; 1990 Feb; 85(2):541-9. PubMed ID: 1688888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preservation of renal structure and function in the rat remnant kidney model of chronic renal failure by enalapril treatment.
    Jackson B; Whitty M; Debrevi L; Cubela R
    Pathology; 1987 Jan; 19(1):38-42. PubMed ID: 3035469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preservation of renal function in the rat remnant kidney model of chronic renal failure by blood pressure reduction.
    Jackson B; Debrevi L; Cubela R; Whitty M; Johnston CI
    Clin Exp Pharmacol Physiol; 1986 Apr; 13(4):319-23. PubMed ID: 3731536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-converting enzyme inhibition in nondiabetic progressive renal insufficiency: a controlled double-blind trial.
    Ihle BU; Whitworth JA; Shahinfar S; Cnaan A; Kincaid-Smith PS; Becker GJ
    Am J Kidney Dis; 1996 Apr; 27(4):489-95. PubMed ID: 8678058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disparate effects of angiotensin converting enzyme inhibitor and calcium blocker treatment on the preservation of renal structure and function following subtotal nephrectomy or streptozotocin-induced diabetes in the rat.
    Jackson B; Cubela R; Debrevi L; Whitty M; Johnston CI
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S167-9. PubMed ID: 2455124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of exercise and enalapril enhances renoprotective and peripheral effects in rats with renal ablation.
    Kanazawa M; Kawamura T; Li L; Sasaki Y; Matsumoto K; Kataoka H; Ito O; Minami N; Sato T; Ootaka T; Kohzuki M
    Am J Hypertens; 2006 Jan; 19(1):80-6. PubMed ID: 16461196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular mechanisms of nephro-protective action of enalapril in experimental chronic renal failure].
    Ciechanowicz A
    Ann Acad Med Stetin; 1999; Suppl 52():1-93. PubMed ID: 10589103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of telmisartan and enalapril on renoprotection in patients with mild to moderate chronic kidney disease.
    Nakamura T; Fujiwara N; Kawagoe Y; Sugaya T; Ueda Y; Koide H
    Eur J Clin Invest; 2010 Sep; 40(9):790-6. PubMed ID: 20584070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin ameliorates renal failure in 5/6 nephrectomized rats: role of inflammation.
    Ghosh SS; Massey HD; Krieg R; Fazelbhoy ZA; Ghosh S; Sica DA; Fakhry I; Gehr TW
    Am J Physiol Renal Physiol; 2009 May; 296(5):F1146-57. PubMed ID: 19225048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of converting enzyme and thromboxane synthetase in a model of progressive renal disease; effects of enalapril and RS-86328 in the rat.
    Rosenkranz RP; Hayashi CM
    Proc West Pharmacol Soc; 1988; 31():81-5. PubMed ID: 2850566
    [No Abstract]   [Full Text] [Related]  

  • 13. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.
    Esnault VL; Brown EA; Apetrei E; Bagon J; Calvo C; DeChatel R; Holdaas H; Krcmery S; Kobalava Z;
    Clin Ther; 2008 Mar; 30(3):482-98. PubMed ID: 18405787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of candesartan cilexetil (TCV-116) and enalapril in 5/6 nephrectomized rats.
    Noda M; Fukuda R; Matsuo T; Ohta M; Nagano H; Imura Y; Nishikawa K; Shibouta Y
    Kidney Int Suppl; 1997 Dec; 63():S136-9. PubMed ID: 9407442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The angiotensin receptor antagonist, irbesartan, reduces renal injury in experimental chronic renal failure.
    Ziai F; Ots M; Provoost AP; Troy JL; Rennke HG; Brenner BM; Mackenzie HS
    Kidney Int Suppl; 1996 Dec; 57():S132-6. PubMed ID: 8941934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The contribution of systemic hypertension to progression of chronic renal failure in the rat remnant kidney: effect of treatment with an angiotensin converting enzyme inhibitor or a calcium inhibitor.
    Jackson B; Johnston CI
    J Hypertens; 1988 Jun; 6(6):495-501. PubMed ID: 2842393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood pressure response to conventional and low-dose enalapril in chronic renal failure.
    Elung-Jensen T; Heisterberg J; Kamper AL; Sonne J; Strandgaard S
    Br J Clin Pharmacol; 2003 Feb; 55(2):139-46. PubMed ID: 12580985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycophenolate mofetil slows progression in anti-thy1-induced chronic renal fibrosis but is not additive to a high dose of enalapril.
    Krämer S; Loof T; Martini S; Rückert M; Wang Y; Böhler T; Shimizu F; Kawachi H; Neumayer HH; Peters H
    Am J Physiol Renal Physiol; 2005 Aug; 289(2):F359-68. PubMed ID: 15769934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of nifedipine and enalapril on glomerular structure and function in uninephrectomized SHR.
    Dworkin LD; Feiner HD; Parker M; Tolbert E
    Kidney Int; 1991 Jun; 39(6):1112-7. PubMed ID: 1895665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrasting renal effects of chronic administrations of enalapril and losartan on one-kidney, one clip hypertensive rats.
    Demeilliers B; Jover B; Mimran A
    J Hypertens; 1998 Jul; 16(7):1023-9. PubMed ID: 9794744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.